Compare Cronos Group Inc (CRON) vs Ecolab Inc. (ECL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Ecolab Inc. — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Ecolab Inc. trades at $281.83 (market cap $78.97B). The key difference: Ecolab Inc. is far larger — about 66.9× Cronos Group Inc's market cap, and Ecolab Inc. pays a 1.04% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Ecolab Inc. for 90 Days on average.
| CRON | ECL | |
|---|---|---|
Market Cap | $1.18B | $78.97B |
Volume | 968,037 | 974,947 |
Sector | Health | Basic Materials |
52-Week High | $3.55 | $308.35 |
52-Week Low | $2.30 | $245.73 |
Typical Hold Time | 22 Days | 90 Days |
Enterprise Value | $387.62M | $87.75B |
Dividend Yield | — | 1.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 0.62% on the day, with a bearish technical signal from moving averages. The company reported strong Q2 2026 results, beating earnings estimates with 58% YoY revenue growth, and maintains a robust balance sheet with $827 million in cash and no debt. Recent investor day highlighted expansion in Canada and international markets.
Outlook is mixed; profitability improved with net income margin turning positive in 2026 forecasts, but high EV/EBITDA of 43 suggests premium valuation. Risks include execution of growth plans and cannabis sector volatility. Analyst consensus is cautious with 60% hold ratings.
ECL trades at $281.69, up 1.29% with strong analyst support (78% buy ratings) and a $326.38 consensus target. The stock shows bullish technical momentum above key support at $279, supported by improving fundamentals including 9.7% Q2 sales growth and consistent dividend increases. Recent institutional buying and director purchases signal confidence ahead of Q3 earnings on October 27.
Outlook remains positive with High-Tech and Digital segments driving growth, though elevated P/E of 37.8 and rising debt from the CoolIT acquisition present valuation and execution risks. The dividend aristocrat status and essential service model provide stability, making ECL attractive for long-term investors despite near-term cost pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →
